287 results on '"Bain, Vincent G."'
Search Results
2. Quantitative blood flow evaluation of vasodilation-stress compared with dobutamine-stress in patients with end-stage liver disease using 82Rb PET/CT
3. Selective Internal Radiation Therapy for Hepatocellular Carcinoma Across the Barcelona Clinic Liver Cancer Stages
4. Acute hepatitis following mRNA BNT162b2 COVID-19 vaccination
5. Muscle Wasting Is Associated With Mortality in Patients With Cirrhosis
6. Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?
7. Is pre-treatment liver biopsy necessary for all hepatitis C genotypes?
8. Serum IgG4 cut-off of 70 mg/dL is associated with a shorter time to cirrhosis decompensation and liver transplantation in primary sclerosing cholangitis patients
9. Hyperhomocysteinemia is associated with severity of cirrhosis and negative impact after liver transplantation
10. Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-α in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 2 or 3
11. Post liver transplantation chronic kidney disease is associated with increased cardiovascular disease risk and poor survival
12. Safety and Antiviral Activity of Albinterferon Alfa-2b Dosed Every Four Weeks in Genotype 2/3 Chronic Hepatitis C Patients
13. Allopurinol to Prevent Pancreatitis After Endoscopic Retrograde Cholangiopancreatography: A Randomized Placebo-Controlled Trial
14. Elevated lipogenesis and diminished cholesterol synthesis in patients with hepatitis C viral infection compared to healthy humans
15. Prevalence of Occult Gastrointestinal Bleeding in Celiac Disease
16. Dynamics of interferon-specific gene expression in peripheral blood of interferon alfa-naïve patients with genotype 1 chronic hepatitis C infection treated with albumin-interferon alfa
17. A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients
18. Severe muscle depletion in patients on the liver transplant wait list: Its prevalence and independent prognostic value
19. Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation
20. Prognostic Value of Muscle Wasting in Cirrhotic Patients
21. Selective Internal Radiation Therapy for Hepatocellular Carcinoma Across the Barcelona Clinic Liver Cancer Stages
22. Alcohol use while on the liver transplant waiting list: A single-center experience
23. Risk factors for recurrence of autoimmune hepatitis after liver transplantation
24. Early prediction of sustained virological response at day 3 of treatment with albinterferon-α-2b in patients with genotype 2/3 chronic hepatitis C
25. A Shorter Duration of Pre-Transplant Abstinence Predicts Problem Drinking After Liver Transplantation
26. The effect of 1 month of therapy with midodrine, octreotide-LAR and albumin in refractory ascites: a pilot study
27. Adult liver transplant survey: policies towards eligibility criteria in Canada and the United States 2007
28. ABO-incompatible liver transplantation for critically ill adult patients
29. The Efficacy and Safety of Bile Acid Binding Agents, Opioid Antagonists, or Rifampin in the Treatment of Cholestasis-Associated Pruritus
30. Liver transplantation for incidental cholangiocarcinoma: Analysis of the Canadian experience
31. Simple clinical variables predict liver histology in hepatitis C: Prospective validation of a clinical prediction model
32. Polycystic Liver Disease: Experience at a Teaching Hospital
33. Evaluation of Renal Function in Liver Transplant Recipients Receiving Daclizumab (Zenapax), Mycophenolate Mofetil, and a Delayed, Low-Dose Tacrolimus Regimen Vs. a Standard-Dose Tacrolimus and Mycophenolate Mofetil Regimen: A Multicenter Randomized Clinical Trial
34. Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus
35. Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients treated with interferon α for chronic hepatitis C
36. Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance
37. Chronic viral hepatitis C: management update
38. HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence after Liver Transplantation
39. Late acute rejection after liver transplantation: The Western Canada experience
40. Evolution of autoimmune hepatitis to primary sclerosing cholangitis: A sequential syndrome
41. Predicting the liver histology in chronic hepatitis C: how good is the clinician?
42. Effect of HCV viral dynamics on treatment design: lessons learned from HIV
43. An Unusual Cause of Elevated Liver Enzymes in a Diabetic Patient
44. Validation of the Model of End-Stage Liver Disease for Liver Transplant Allocation in Alberta: Implications for Future Directions in Canada
45. Hyperhomocysteinemia is associated with severity of cirrhosis and negative impact after liver transplantation
46. Bioartificial Liver Support
47. Sarcopenia as a Prognostic Index of Nutritional Status in Concurrent Cirrhosis and Hepatocellular Carcinoma
48. Reply
49. Incidence and risk factors associated withde novoautoimmune hepatitis after liver transplantation
50. Cardiac Work-Up Protocol for Liver Transplant Candidates: Experience from a Single Liver Transplant Centre
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.